August 2026 FDA Recall Clobetasol Propionate by Lupin Pharmaceuticals Inc.
D-0789-2026 - Failed content uniformity specifications.

This Class II drug recall was voluntarily initiated by Lupin Pharmaceuticals Inc. on August 3, 2026 for the product Clobetasol Propionate. The FDA reported the reason for recall as failed content uniformity specifications.. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0789-2026

Reason for Recall
Failed content uniformity specifications.
Initiated
08-03-2026
Reported
09-02-2026
Quantity
5082 tubes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Lupin Pharmaceuticals Inc.
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Clobetasol Propionate Cream USP, 0.05%, 60 g tube, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Pithampur (MP) 454 775, INDIA, NDC 68180-956-04.

Batch or Lot Expiration Information

Lot# : KB00427, Exp date 4/30/2028; KA00308, Exp date 10/31/2026